tiprankstipranks

Pierre Gravier Insider Profile

4 Followers
Pierre Gravier, CFO at PTC Therapeutics, holds 53.53K shares in PTC Therapeutics (Ticker: PTCT), holds ― shares in Cassava Sciences (Ticker: SAVA). Most recently, Pierre Gravier Sold ― shares of PTC Therapeutics on Jul 18, 2024 for an estimated value of 77.19K.
tipranks
Pierre Gravier

Pierre Gravier
PTC Therapeutics (PTCT)
CFO

Ranked #59,749 out of 100,202 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-11.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
A breakdown of Pierre Gravier's holdings

Insider Roles

PTC Therapeutics
(PTCT)
CFO
Cassava Sciences
(SAVA)
Director
Roles that Pierre Gravier holds in companies

Most Profitable Insider Trade

Stock:
PTC Therapeutics
(PTCT)
Rating:Informative Buy
Date:Dec 14, 2023 - Dec 14, 2024
Return:+18.80%
The most profitable trade made by Pierre Gravier

Pierre Gravier's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PTC Therapeutics
Jul 18, 2024
CFO
Informative Sell
77.19K
$2.48M
Cassava Sciences
Director
List of latest transactions for each holding click on a transaction to see Pierre Gravier's performance on stock

Pierre Gravier insider profile FAQ

What is the percentage of profitable transactions made by Pierre Gravier?
The percentage of profitable transactions made by Pierre Gravier is 50%.
    What is the average return per transaction made by Pierre Gravier?
    The average return per transaction made by Pierre Gravier is -11.00%.
      What stocks does Pierre Gravier hold?
      Pierre Gravier holds: PTCT, SAVA stocks.
        What was Pierre Gravier’s latest transaction?
        Pierre Gravier latest transaction was an Informative Sell of $77.19K.
          What was Pierre Gravier's most profitable transaction?
          Pierre Gravier’s most profitable transaction was an Informative Buy of PTCT stock on December 14, 2023. The return on the trade was 18.80%.
            What is Pierre Gravier's role in PTC Therapeutics?
            Pierre Gravier's role in PTC Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.